Skip to main content

fanapt

Generic: iloperidone

fanapt: sourced relationships with 1 company · 1 FDA decision.

fanapt evidence translation

What we can confirm

What it means

Source-backed records connect fanapt to VNDA; that link alone does not prove the drug works.

What to watch

Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected

Prepared research question

How could fanapt → VNDA affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (1)
CompanyDated record stage
Vanda Pharmaceuticals Inc. (VNDA)
Reported 2009-05-06 · Current development: unknownSource
Approved
FDA Decisions1 records
Approval1 INDICATIONS AND USAGE FANAPT ® is indicated for: Treatment of schizophrenia in adults [see Clinical Studies (14.1) ]. Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] . FANAPT is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 , 14.1 ) Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. ( 1 , 14.2 )(VNDA)FDA ↗
NDA022192Type 1 - New Molecular EntityStandardOralTablet

Frequently asked questions

Which companies have sourced relationships with fanapt?

fanapt has dated SEC/FDA relationship records for Vanda Pharmaceuticals Inc..

What is fanapt's latest FDA decision?

The most recent tracked FDA decision for fanapt is Approval for 1 INDICATIONS AND USAGE FANAPT ® is indicated for: Treatment of schizophrenia in adults [see Clinical Studies (14.1) ]. Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults [see Clinical Studies (14.2) ] . FANAPT is an atypical antipsychotic indicated for: Treatment of schizophrenia in adults. ( 1 , 14.1 ) Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. ( 1 , 14.2 ), dated May 6, 2009.